Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Molecular Partners AG American Depositary Shares

MOLN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of MOLN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
MOLN Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MOLN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MOLN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in MOLN holdings by institutional investors

Quarterly net insider trading by MOLN's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for MOLN

9 former government officials from 4 congressional offices at 6 lobbying firms have lobbied for MOLN, most recently Jul 20, 2023.

  • Alexander Hecht Senate New Chief Counsel, Senate Committee on Small Business & Entrepreneurship Formerly Chief Counsel, Senate Committee on Small Business & Entrepreneurship · ML STRATEGIES, LLC · Jul 20, 2023
  • Andrew Vogt Senate New Senate HELP Committee Formerly Senate HELP Committee · HART HEALTH STRATEGIES · Apr 13, 2023
  • Mark Kirk
    Andrew Vogt Senate Health Professional Staff Member, Senate Health, Education, Labor, and Pensions Committee; Legislative Assistant, Senator Mark Kirk Formerly with Mark Kirk · ANDREW VOGT STRATEGIES LLC · Oct 10, 2022
  • Mick Mulvaney
    Al Simpson House 2011-2017 COS REP Mick Mulvaney; Formerly with Mick Mulvaney · MERCURY PUBLIC AFFAIRS, LLC · Jul 20, 2021
  • Rodney Frelinghuysen House New U.S. Congressman (1995 - 2019) Formerly U.S. Congressman (1995 - 2019) · GREENBERG TRAURIG, LLP · Oct 21, 2020
  • Tim Hutchinson Congress New U.S. Senator (97-03); U.S. Congressman (93-97) Formerly U.S. Senator (97-03); U.S. Congressman (93-97) · GREENBERG TRAURIG, LLP · Apr 19, 2019
  • Albert Wynn House New U.S. Congressman (92-08) Formerly U.S. Congressman (92-08) · GREENBERG TRAURIG, LLP · Jan 18, 2019
  • Doris O. Matsui
    Clare Chmiel House New Rep. Doris Matsui, Scheduler Formerly with Doris O. Matsui · BRYAN CAVE LEIGHTON PAISNER LLP · Jul 19, 2018
See all 9 on the Revolving Door dashboard

MOLN Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

MOLN Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
MOLN Income Statement
MOLN Balance Sheet
MOLN Cash Flow
U.S. Patents

New MOLN patent grants

  • Patent Title: Designed ankyrin repeat domain with improved stability Oct. 14, 2025
  • Patent Title: Designed ankyrin repeat domains with altered surface residues Oct. 07, 2025
  • Patent Title: Multispecific proteins Jun. 17, 2025
  • Patent Title: Darpin based multi-specific t-cell engagers Dec. 05, 2023
  • Patent Title: Designed ankyrin repeat domains with altered surface residues Feb. 14, 2023
  • Patent Title: Ankyrin repeat binding proteins and their uses Oct. 11, 2022
  • Patent Title: Designed ankyrin repeat proteins binding to hepatocyte growth factor Sep. 27, 2022
  • Patent Title: Recombinant binding proteins and their use May. 17, 2022
  • Patent Title: Recombinant binding proteins targeting her2 and serum albumin, and their uses Jul. 21, 2020
  • Patent Title: Modified binding proteins inhibiting the vegf-a receptor interaction May. 12, 2020
  • Patent Title: Binding proteins comprising at least two repeat domains against her2 Aug. 06, 2019
  • Patent Title: Capping modules for designed ankyrin repeat proteins Jun. 18, 2019
  • Patent Title: Recombinant binding proteins and their use Dec. 18, 2018
  • Patent Title: Modified binding proteins inhibiting the vegf-a receptor interaction Dec. 26, 2017
  • Patent Title: Designed repeat proteins binding to serum albumin Oct. 03, 2017
  • Patent Title: Capping modules for designed ankyrin repeat proteins Aug. 01, 2017
  • Patent Title: Recombinant proteins that simultaneously bind hgf, vegf-a and serum albumin, comprising ankyrin repeat domains Oct. 04, 2016
  • Patent Title: Modified binding proteins inhibiting the vegf-a receptor interaction Mar. 22, 2016
  • Patent Title: Designed repeat proteins binding to serum albumin Mar. 15, 2016
  • Patent Title: Capping modules for designed ankyrin repeat proteins Dec. 29, 2015
  • Patent Title: Designed ankyrin repeat proteins binding to platelet-derived growth factor Oct. 20, 2015
  • Patent Title: Binding proteins inhibiting the vegf-a receptor interaction Dec. 02, 2014
  • Patent Title: Modified binding proteins inhibiting the vegf-a receptor interaction Apr. 29, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to MOLN from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
MOLN News

Recent insights relating to MOLN

CNBC Recommendations

Recent picks made for MOLN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MOLN

MOLN Analyst Ratings

MOLN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MOLN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MOLN stock a Buy, Sell, or Hold?

  • What is the price target for $MOLN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MOLN Top Shareholders
Shareholder
Shares Held
MOLN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MOLN stock?

  • Who owns the most shares of $MOLN stock?

  • What funds own $MOLN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MOLN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MOLN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MOLN

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Molecular Partners AG American Depositary Shares (MOLN) Historical Stock Prices

Molecular Partners AG American Depositary Shares (MOLN) closed at $4.30 on September 23, 2026. Over the past year its adjusted close ranged from $3.54 to $5.12. Daily prices go back to June 16, 2021, 1,211 trading days in all.

  • 1 month-2.27%
  • 3 months+13.16%
  • Year to date-1.34%
  • 1 year+17.17%
  • 3 years-8.51%
  • 5 years-77.62%
  • Max-78.12%
See every congressional and insider trade on the MOLN price chart

Quiver Premium charts MOLN's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 4.30 4.30 4.30 4.30 4.30 286
Sep 22, 2026 4.26 4.26 4.26 4.26 4.26 1,008
Sep 21, 2026 4.08 4.08 3.97 3.99 3.99 4,020
Sep 18, 2026 4.02 4.72 4.02 4.21 4.21 2,857
Sep 16, 2026 3.84 4.02 3.84 3.92 3.92 2,099
Sep 15, 2026 3.99 4.20 3.90 4.20 4.20 3,672
Sep 14, 2026 4.15 4.15 4.00 4.02 4.02 1,630
Sep 10, 2026 4.18 4.20 4.18 4.18 4.18 1,066
Sep 4, 2026 4.35 4.35 4.35 4.35 4.35 2,166
Sep 3, 2026 4.35 4.35 4.35 4.35 4.35 282
Sep 2, 2026 4.07 4.07 4.07 4.07 4.07 282
Sep 1, 2026 4.38 4.38 4.29 4.29 4.29 968
Aug 28, 2026 4.67 4.67 4.50 4.50 4.50 1,553
Aug 27, 2026 4.60 4.65 4.56 4.65 4.65 4,720
Aug 26, 2026 4.49 4.49 4.42 4.45 4.45 2,390
Aug 25, 2026 4.35 4.38 4.13 4.38 4.38 2,111
Aug 24, 2026 4.30 4.40 4.30 4.40 4.40 1,913
Aug 21, 2026 4.38 4.40 4.38 4.40 4.40 504
Aug 20, 2026 4.24 4.25 4.23 4.23 4.23 3,663
Aug 19, 2026 4.30 4.33 4.30 4.33 4.33 443
Aug 18, 2026 4.25 4.29 4.25 4.29 4.29 534
Aug 17, 2026 4.25 4.25 4.25 4.25 4.25 1,545
Aug 14, 2026 4.19 4.21 4.11 4.21 4.21 1,037
Aug 13, 2026 4.21 4.21 4.21 4.21 4.21 1,315
Aug 10, 2026 4.13 4.13 4.13 4.13 4.13 217
Aug 6, 2026 4.05 4.05 4.02 4.05 4.05 722
Aug 4, 2026 4.16 4.16 4.16 4.16 4.16 254
Aug 3, 2026 4.25 4.25 4.07 4.12 4.12 6,089
Jul 29, 2026 3.93 3.93 3.93 3.93 3.93 350
Jul 28, 2026 3.92 3.92 3.83 3.83 3.83 436
Jul 27, 2026 4.00 4.00 4.00 4.00 4.00 641
Jul 24, 2026 3.92 3.92 3.89 3.89 3.89 1,047
Jul 22, 2026 3.97 3.97 3.97 3.97 3.97 269
Jul 21, 2026 4.11 4.11 4.11 4.11 4.11 760
Jul 20, 2026 4.04 4.04 4.00 4.00 4.00 2,750
Jul 17, 2026 4.09 4.09 3.90 3.90 3.90 2,187
Jul 16, 2026 4.01 4.10 4.01 4.10 4.10 824
Jul 15, 2026 3.72 4.00 3.72 3.91 3.91 1,610
Jul 14, 2026 4.00 4.00 4.00 4.00 4.00 886
Jul 13, 2026 3.90 4.01 3.90 4.01 4.01 1,363
Jul 9, 2026 3.95 4.02 3.95 4.02 4.02 2,345
Jul 8, 2026 4.09 4.09 4.09 4.09 4.09 556
Jul 7, 2026 4.00 4.09 3.99 4.09 4.09 9,127
Jul 6, 2026 3.98 4.05 3.96 4.00 4.00 30,180
Jul 2, 2026 4.10 4.17 3.96 3.98 3.98 46,739
Jul 1, 2026 3.81 3.93 3.81 3.93 3.93 5,270
Jun 30, 2026 3.82 3.87 3.82 3.87 3.87 903
Jun 29, 2026 3.80 4.01 3.78 3.96 3.96 9,077
Jun 26, 2026 3.90 3.90 3.75 3.80 3.80 11,323
Jun 25, 2026 3.98 3.98 3.90 3.93 3.93 3,886
Jun 24, 2026 3.90 3.90 3.73 3.80 3.80 13,851
Jun 23, 2026 3.96 3.97 3.81 3.81 3.81 27,268
Jun 22, 2026 4.00 4.00 3.95 3.95 3.95 7,572
Jun 18, 2026 3.98 3.98 3.82 3.82 3.82 1,041
Jun 17, 2026 3.94 4.00 3.86 3.90 3.90 5,009
Jun 16, 2026 3.82 4.05 3.72 3.92 3.92 24,540
Jun 15, 2026 3.85 3.85 3.85 3.85 3.85 5,741
Jun 12, 2026 4.11 4.11 4.11 4.11 4.11 1,848
Jun 11, 2026 3.78 3.78 3.71 3.71 3.71 796
Jun 10, 2026 3.71 3.80 3.71 3.72 3.72 4,515
Jun 9, 2026 3.82 3.88 3.67 3.88 3.88 2,306
Jun 8, 2026 3.90 3.95 3.75 3.95 3.95 6,171
Jun 5, 2026 4.03 4.10 4.03 4.10 4.10 2,080
Jun 4, 2026 3.95 3.95 3.93 3.93 3.93 2,330
Jun 3, 2026 3.78 4.12 3.78 4.03 4.03 14,617
Jun 2, 2026 4.00 4.07 3.92 3.92 3.92 6,280
Jun 1, 2026 3.95 3.95 3.95 3.95 3.95 1,014
May 29, 2026 4.11 4.20 4.11 4.20 4.20 1,191
May 28, 2026 4.02 4.02 4.00 4.00 4.00 3,907
May 27, 2026 4.04 4.04 4.04 4.04 4.04 3,744
May 26, 2026 4.05 4.05 4.05 4.05 4.05 4,569
May 22, 2026 4.00 4.35 4.00 4.18 4.18 10,796
May 21, 2026 3.71 3.99 3.66 3.80 3.80 18,104
May 20, 2026 3.89 4.09 3.74 3.74 3.74 17,140
May 19, 2026 3.71 3.74 3.71 3.74 3.74 4,739
May 18, 2026 3.71 3.80 3.71 3.80 3.80 7,043
May 14, 2026 3.85 3.85 3.80 3.84 3.84 3,096
May 13, 2026 3.93 4.03 3.93 4.00 4.00 4,261
May 12, 2026 4.12 4.12 4.04 4.04 4.04 5,480
May 11, 2026 4.11 4.28 4.11 4.13 4.13 16,996
May 8, 2026 4.10 4.10 4.10 4.10 4.10 5,856
May 7, 2026 4.21 4.21 4.10 4.10 4.10 4,128
May 6, 2026 4.20 4.29 4.20 4.29 4.29 2,469
May 5, 2026 4.20 4.25 4.20 4.25 4.25 6,363
May 4, 2026 4.26 4.41 4.26 4.41 4.41 2,541
May 1, 2026 4.52 4.52 4.24 4.24 4.24 1,982
Apr 30, 2026 4.20 4.25 4.20 4.23 4.23 1,519
Apr 29, 2026 4.45 4.45 4.45 4.45 4.45 1,323
Apr 28, 2026 4.28 4.28 4.28 4.28 4.28 832
Apr 27, 2026 4.35 4.35 4.35 4.35 4.35 1,693
Apr 24, 2026 4.47 4.47 4.46 4.46 4.46 1,086
Apr 23, 2026 4.40 4.47 4.40 4.40 4.40 2,176
Apr 22, 2026 4.34 4.34 4.34 4.34 4.34 1,309
Apr 21, 2026 4.42 4.42 4.35 4.35 4.35 924
Apr 20, 2026 4.37 4.53 4.26 4.41 4.41 6,737
Apr 17, 2026 4.18 4.21 4.18 4.21 4.21 2,753
Apr 16, 2026 4.18 4.18 4.18 4.18 4.18 2,158
Apr 15, 2026 4.15 4.20 4.15 4.20 4.20 1,091
Apr 14, 2026 4.14 4.14 4.14 4.14 4.14 4,632
Apr 13, 2026 4.11 4.21 4.00 4.21 4.21 11,698
Apr 9, 2026 4.10 4.34 4.10 4.33 4.33 3,413
Apr 8, 2026 4.26 4.46 4.01 4.24 4.24 2,283
Apr 7, 2026 3.93 4.10 3.86 3.87 3.87 5,332
Apr 6, 2026 4.04 4.04 4.04 4.04 4.04 396
Apr 2, 2026 3.87 4.07 3.84 3.85 3.85 3,272
Apr 1, 2026 4.00 4.10 4.00 4.00 4.00 4,440
Mar 31, 2026 3.91 4.00 3.91 3.97 3.97 1,728
Mar 30, 2026 3.99 3.99 3.71 3.93 3.93 2,744
Mar 27, 2026 4.20 4.20 4.05 4.05 4.05 1,841
Mar 26, 2026 4.21 4.30 4.21 4.30 4.30 1,124
Mar 25, 2026 4.43 4.43 4.25 4.31 4.31 1,310
Mar 24, 2026 4.36 4.41 4.35 4.35 4.35 1,395
Mar 23, 2026 4.38 4.56 4.38 4.51 4.51 1,137
Mar 20, 2026 4.68 4.72 4.39 4.58 4.58 2,720
Mar 19, 2026 4.69 4.69 4.69 4.69 4.69 1,866
Mar 18, 2026 4.63 4.80 4.39 4.54 4.54 6,908
Mar 17, 2026 4.33 4.43 4.20 4.34 4.34 11,650
Mar 16, 2026 4.22 5.01 4.22 4.34 4.34 13,766
Mar 13, 2026 4.63 4.63 4.10 4.22 4.22 13,223
Mar 12, 2026 4.98 5.00 4.71 4.71 4.71 6,324
Mar 11, 2026 5.03 5.03 4.86 4.86 4.86 972
Mar 10, 2026 4.88 5.31 4.88 4.88 4.88 3,384
Mar 9, 2026 4.98 5.00 4.88 4.90 4.90 2,346
Mar 6, 2026 4.99 5.10 4.99 5.00 5.00 1,493
Mar 5, 2026 4.93 4.93 4.93 4.93 4.93 619
Mar 3, 2026 4.94 5.28 4.93 4.93 4.93 2,759
Mar 2, 2026 5.12 5.12 5.12 5.12 5.12 790
Feb 27, 2026 5.10 5.36 5.01 5.02 5.02 5,976
Feb 26, 2026 5.00 5.11 4.88 4.88 4.88 3,609
Feb 25, 2026 5.11 5.11 5.05 5.05 5.05 1,021
Feb 24, 2026 4.93 5.02 4.93 5.02 5.02 2,412
Feb 19, 2026 4.70 5.00 4.63 5.00 5.00 5,726
Feb 18, 2026 4.73 4.73 4.73 4.73 4.73 369
Feb 17, 2026 4.64 4.75 4.54 4.75 4.75 1,371
Feb 13, 2026 4.45 4.61 4.45 4.61 4.61 918
Feb 11, 2026 4.72 4.72 4.65 4.65 4.65 651
Feb 10, 2026 4.74 4.74 4.74 4.74 4.74 308
Feb 9, 2026 4.68 4.68 4.65 4.65 4.65 802
Feb 6, 2026 4.61 4.73 4.54 4.70 4.70 2,111
Feb 5, 2026 4.49 4.75 4.40 4.61 4.61 11,103
Feb 4, 2026 4.49 4.62 4.33 4.40 4.40 4,136
Feb 3, 2026 4.73 4.73 4.50 4.50 4.50 7,810
Feb 2, 2026 4.60 4.60 4.35 4.57 4.57 8,807
Jan 30, 2026 4.25 4.25 4.09 4.25 4.25 4,344
Jan 29, 2026 4.13 4.28 4.01 4.15 4.15 5,984
Jan 28, 2026 4.03 4.26 4.03 4.16 4.16 6,966
Jan 27, 2026 4.21 4.27 4.00 4.00 4.00 27,734
Jan 26, 2026 4.15 4.15 4.00 4.00 4.00 2,605
Jan 23, 2026 4.00 4.29 4.00 4.09 4.09 6,424
Jan 22, 2026 4.06 4.08 3.99 4.01 4.01 5,379
Jan 21, 2026 4.06 4.06 3.96 4.04 4.04 3,705
Jan 20, 2026 4.21 4.21 4.05 4.05 4.05 10,504
Jan 16, 2026 4.20 4.24 4.20 4.20 4.20 1,442
Jan 15, 2026 4.27 4.28 4.14 4.28 4.28 4,115
Jan 14, 2026 4.12 4.23 4.11 4.21 4.21 2,743
Jan 13, 2026 4.15 4.28 4.13 4.13 4.13 3,913
Jan 12, 2026 4.09 4.31 4.09 4.17 4.17 9,817
Jan 9, 2026 4.13 4.22 4.10 4.10 4.10 2,682
Jan 8, 2026 4.15 4.44 4.12 4.25 4.25 17,064
Jan 7, 2026 4.22 4.48 4.22 4.26 4.26 3,162
Jan 6, 2026 4.31 4.38 4.25 4.38 4.38 1,808
Jan 5, 2026 4.25 4.25 4.21 4.21 4.21 1,374
Jan 2, 2026 4.39 4.39 4.21 4.22 4.22 1,331
Dec 31, 2025 4.32 4.36 4.30 4.36 4.36 1,260
Dec 30, 2025 4.29 4.34 4.20 4.30 4.30 4,297
Dec 29, 2025 4.19 4.43 4.19 4.43 4.43 1,977
Dec 26, 2025 4.16 4.44 4.16 4.23 4.23 3,736
Dec 24, 2025 4.34 4.34 4.34 4.34 4.34 147
Dec 23, 2025 4.40 4.40 4.20 4.34 4.34 12,249
Dec 22, 2025 4.32 4.60 4.32 4.59 4.59 6,502
Dec 19, 2025 4.37 4.39 4.33 4.39 4.39 3,724
Dec 18, 2025 4.21 4.40 4.21 4.28 4.28 2,211
Dec 17, 2025 4.20 4.26 3.98 4.23 4.23 3,386
Dec 16, 2025 4.09 4.18 4.01 4.18 4.18 5,573
Dec 15, 2025 4.35 4.35 3.92 4.08 4.08 20,607
Dec 12, 2025 4.33 4.33 4.33 4.33 4.33 521
Dec 11, 2025 4.57 4.57 4.47 4.48 4.48 1,323
Dec 10, 2025 4.40 4.49 4.28 4.28 4.28 1,568
Dec 9, 2025 4.17 4.33 4.15 4.31 4.31 1,825
Dec 8, 2025 4.29 4.29 4.13 4.20 4.20 3,527
Dec 5, 2025 4.39 4.52 4.39 4.52 4.52 1,271
Dec 4, 2025 4.33 4.51 4.32 4.51 4.51 1,135
Dec 3, 2025 4.26 4.61 4.26 4.45 4.45 10,496
Dec 2, 2025 4.25 4.34 4.25 4.32 4.32 1,491
Dec 1, 2025 4.20 4.20 3.99 4.02 4.02 2,663
Nov 28, 2025 4.05 4.12 4.05 4.12 4.12 469
Nov 26, 2025 4.11 4.11 4.10 4.10 4.10 717
Nov 24, 2025 4.11 4.11 4.00 4.00 4.00 976
Nov 21, 2025 4.11 4.11 3.99 4.04 4.04 2,156
Nov 20, 2025 4.07 4.23 4.07 4.12 4.12 5,359
Nov 19, 2025 4.28 4.32 4.19 4.19 4.19 1,190
Nov 18, 2025 4.09 4.28 3.98 4.12 4.12 4,033
Nov 17, 2025 4.34 4.40 4.12 4.26 4.26 2,133
Nov 14, 2025 4.10 4.22 4.07 4.22 4.22 2,213
Nov 13, 2025 4.16 4.28 4.16 4.28 4.28 1,246
Nov 12, 2025 4.18 4.46 3.98 4.13 4.13 59,099
Nov 11, 2025 3.87 4.17 3.87 4.03 4.03 8,923
Nov 10, 2025 4.10 4.69 4.03 4.25 4.25 5,983
Nov 7, 2025 3.97 4.75 3.97 4.74 4.74 3,567
Nov 6, 2025 4.32 4.75 4.32 4.68 4.68 5,620
Nov 5, 2025 4.02 4.21 3.98 4.03 4.03 9,582
Nov 4, 2025 4.11 4.26 3.72 3.91 3.91 22,126
Nov 3, 2025 3.98 4.72 3.80 4.08 4.08 80,700
Oct 31, 2025 3.74 3.74 3.63 3.63 3.63 748
Oct 30, 2025 3.77 3.77 3.77 3.77 3.77 1,219
Oct 28, 2025 3.77 3.77 3.75 3.75 3.75 399
Oct 27, 2025 3.53 3.65 3.53 3.59 3.59 1,541
Oct 24, 2025 3.60 3.60 3.54 3.54 3.54 1,420
Oct 23, 2025 3.74 3.74 3.56 3.56 3.56 4,100
Oct 21, 2025 3.66 3.78 3.66 3.70 3.70 2,448
Oct 20, 2025 3.69 3.81 3.69 3.81 3.81 841
Oct 17, 2025 3.77 3.92 3.77 3.92 3.92 926
Oct 16, 2025 3.70 3.85 3.70 3.85 3.85 792
Oct 15, 2025 3.81 3.81 3.81 3.81 3.81 588
Oct 14, 2025 3.81 3.81 3.60 3.73 3.73 3,295
Oct 13, 2025 3.89 3.91 3.75 3.79 3.79 3,126
Oct 10, 2025 3.76 3.80 3.68 3.80 3.80 811
Oct 8, 2025 4.00 4.00 3.72 3.89 3.89 9,696
Oct 7, 2025 3.69 3.75 3.69 3.71 3.71 2,181
Oct 6, 2025 3.71 3.75 3.70 3.75 3.75 2,361
Oct 3, 2025 3.75 3.75 3.71 3.71 3.71 1,531
Oct 2, 2025 3.70 3.76 3.70 3.71 3.71 2,737
Oct 1, 2025 3.70 3.76 3.68 3.71 3.71 1,452
Sep 30, 2025 3.69 3.80 3.65 3.71 3.71 3,651
Sep 29, 2025 3.82 3.82 3.68 3.68 3.68 409
Sep 26, 2025 3.62 3.85 3.62 3.85 3.85 2,749
Sep 25, 2025 3.58 3.61 3.57 3.61 3.61 876
Sep 24, 2025 3.79 3.79 3.68 3.68 3.68 883

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Molecular Partners AG American Depositary Shares Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at MOLN, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation